Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02696564 · ClinicalTrials.gov registry record · Phase 4
Losartan Effects on Emphysema Progression
A Phase 4 study of Emphysema, sponsored by JHSPH Center for Clinical Trials.
- Completed
- Registry status
- Phase 4
- Development phase
- 220
- Enrollment target
- 20
- Study locations
NCT02696564: Completed Phase 4 study of Emphysema, sponsored by JHSPH Center for Clinical Trials.
NCT02696564 is a Phase 4 study of Emphysema that has completed, run by JHSPH Center for Clinical Trials. The registered enrollment target is 220 participants, below the 3,795-participant average among 25 other Emphysema trials with a reported enrollment target (94% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02696564, a Phase 4 study of Emphysema, has completed, sponsored by JHSPH Center for Clinical Trials.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 220 participants
- Enrollment target
- 20
- Study locations
Study Summary
A randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to placebo .
Primary Outcome
change in percentage of voxels with density less than -950 Hounsfield Units
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Losartan
Study Locations (20)
Illinois
- University of Illinois at Chicago - Chicago
- Northwestern University - Chicago
- Rush University Medical Center - Chicago
- University of Chicago Hospitals - Chicago
California
- University of California at San Diego - San Diego
- University of California at San Francisco - San Francisco
Florida
- University of Florida College of Medicine - Jacksonville
- University of South Florida - Tampa
Missouri
- St. Louis University School of Medicine - St Louis
- St. Louis Asthma Clinical Research Center - Washington University School of Medicine - St Louis
New York
- New York University School of Medicine - New York
- Weill Cornell Medicine - New York
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- University of Arizona - Tucson
Colorado
- National Jewish Medical and Research Center - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2017-05-23 |
| Est. Completion | 2021-06-30 |
| Phase | Phase 4 |
What the finished NCT02696564 record still lists
NCT02696564 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 3,795-participant average among 25 other Emphysema trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Emphysema appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02696564 names 20 study sites across 13 states, led by Illinois, California, Florida.
Frequently Asked Questions
What is clinical trial NCT02696564 about?
NCT02696564 is a clinical study titled "Losartan Effects on Emphysema Progression". A randomized, parallel, placebo controlled trial to evaluate the effect of 100mg/day losartan on the progression of emphysema as measured by quantitative HRCT compared to placebo .
What is the current status of trial NCT02696564?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 220 participants. The study started on 2017-05-23. Estimated completion is 2021-06-30.
What conditions does trial NCT02696564 study?
This clinical trial studies the following conditions: Emphysema.
What interventions are being tested in trial NCT02696564?
The interventions under investigation include: Placebo (DRUG), Losartan (DRUG).
Who is sponsoring clinical trial NCT02696564?
This trial is sponsored by JHSPH Center for Clinical Trials, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02696564 being conducted?
This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Emphysema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02696564's enrollment target sits among peer trials
220 10th of 25 higher than 16 of 25 other Emphysema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Emphysema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema
ACTIVE NOT RECRUITING · Phase 4
-
Airway Clearance for Prevention of Chronic Obstructive Pulmonary Disease (COPD) Exacerbation
COMPLETED · Phase 4
-
COPD Patient-Powered Research Network
RECRUITING
-
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
RECRUITING
-
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
RECRUITING · Phase 2
-
Biological Effects of Quercetin in COPD Phase II
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI